34723229|PMC8547804
{'Chemical', 'Disease', 'Species', 'CellLine', 'Gene'}
The first WHO International Standard and International Reference Panel for anti-SARS-CoV-2 immunoglobulin were established by the WHO Expert Committee on Biological Standardization in December, 2020. As examples of the measurement standards for COVID-19, the first WHO International Standard for anti-SARS-CoV-2 immunoglobulin with an assigned unitage of 250 International Units (IU) per ampoule (neutralising antibody activity) and the first WHO International Reference Panel for anti-SARS-CoV-2 immunoglobulin were established by the WHO Expert Committee on Biological Standardization on Dec 10, 2020. Table 1 summarises three clinical trials of adenovirus-vectored vaccine candidates that were published in 2020.